ID: ALA5267349

Max Phase: Preclinical

Molecular Formula: C26H21N3O6S

Molecular Weight: 503.54

Representations

Canonical SMILES:  CCOc1ccc(S(=O)(=O)Nc2ccccc2C#Cc2cnc(C(=O)O)cc2OC)c2ncccc12

Standard InChI:  InChI=1S/C26H21N3O6S/c1-3-35-22-12-13-24(25-19(22)8-6-14-27-25)36(32,33)29-20-9-5-4-7-17(20)10-11-18-16-28-21(26(30)31)15-23(18)34-2/h4-9,12-16,29H,3H2,1-2H3,(H,30,31)

Standard InChI Key:  WIQKPAGMWRUXEO-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 503.54

Molecular Weight (Monoisotopic): 503.1151

AlogP: 3.94

#Rotatable Bonds: 7

Polar Surface Area: 127.71

Molecular Species: ACID

HBA: 7

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 1.25

CX Basic pKa: 4.41

CX LogP: 3.61

CX LogD: -0.25

Aromatic Rings: 4

Heavy Atoms: 36

QED Weighted: 0.36

Np Likeness Score: -1.05

References

1. Heinrich T, Sala-Hojman A, Ferretti R, Petersson C, Minguzzi S, Gondela A, Ramaswamy S, Bartosik A, Czauderna F, Crowley L, Wahra P, Schilke H, Böpple P, Dudek Ł, Leś M, Niedziejko P, Olech K, Pawlik H, Włoszczak Ł, Zuchowicz K, Suarez Alvarez JR, Martyka J, Sitek E, Mikulski M, Szczęśniak J, Jäckel S, Krier M, Król M, Wegener A, Gałęzowski M, Nowak M, Becker F, Herhaus C..  (2021)  Discovery of 5-{2-[5-Chloro-2-(5-ethoxyquinoline-8-sulfonamido)phenyl]ethynyl}-4-methoxypyridine-2-carboxylic Acid, a Highly Selective in Vivo Useable Chemical Probe to Dissect MCT4 Biology.,  64  (16.0): [PMID:34382802] [10.1021/acs.jmedchem.1c00448]

Source

Source(1):

• Scientific Literature